EPISODE · Jan 23, 2022 · 56 MIN
Dr Tohru Minamino, MD, PhD - Cardiovascular Aging & Targeted Senolytic Bio-Therapies - Juntendo University
from Progress, Potential, and Possibilities Podcast / Show · host Ira Pastor / Dr. Tohru Minamino
Send us Fan MailDr. Tohru Minamino is Professor and Chairman of the Department of Cardiovascular Biology and Medicine, Juntendo University Graduate School of Medicine (https://juntendo-cvbm.com/en/about.html). He also serves as Director of the Cardiovascular Medicine, Juntendo University Hospital. He received his MD from the Chiba University Graduate School of Medicine in 1989 and his PhD from Faculty of Medicine, the University of Tokyo in 1997. Dr. Minamino is a medical cardiologist and research scientist focusing on molecular mechanisms of aging. He started his major research focusing on cardiovascular aging at Harvard Medical School (1997–2000), and his research interests have currently been growing in the biology of aging including metabolic pathways of longevity and senolysis. He has published more than 100 papers including in Nature, Nature Medicine, Cell, Cell Metabolism, and Lancet. Dr. Minamino has won several awards including Satoh Memorial Award in Japanese Circulation Society, and Erwin von Bälz Award (1st prize). Support the show
What this episode covers
Send us Fan Mail Dr. Tohru Minamino is Professor and Chairman of the Department of Cardiovascular Biology and Medicine, Juntendo University Graduate School of Medicine (https://juntendo-cvbm.com/en/about.html). He also serves as Director of the Cardiovascular Medicine, Juntendo University Hospital. He received his MD from the Chiba University Graduate School of Medicine in 1989 and his PhD from Faculty of Medicine, the University of Tokyo in 1997. Dr. Minamino is a medical cardiologist and re...
NOW PLAYING
Dr Tohru Minamino, MD, PhD - Cardiovascular Aging & Targeted Senolytic Bio-Therapies - Juntendo University
No transcript for this episode yet
Similar Episodes
Mar 26, 2026 ·1m
Mar 19, 2026 ·34m
Feb 18, 2026 ·11m
Feb 11, 2026 ·45m